22 Jan 2021 --- Gelita is broadening its proprietary portfolio of Bioactive Collagen Peptides (BCP) with Immupept, a new brand that targets the immunity sector. Prior to this launch, the company’s latest research collaboration with the Collagen Research Institute revealed an immune-modulating effect from the BCPs in Immupept.
